BRENDA WINSKI: Open Payments
NPI 1174711618 · MICHIGAN CITY, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,172 in 51 payments from 17 companies in 2025. Trend: 2023 $1,133 · 2024 $1,482 · 2025 $1,172
Food & beverage: $993Education: $179
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 5 | $235 |
| Galderma Laboratories, L.P. | 5 | $147 |
| PFIZER INC. | 8 | $140 |
| ABBVIE INC. | 5 | $103 |
| Novartis Pharmaceuticals Corporation | 4 | $98 |
| Organon LLC | 7 | $76 |
| GENZYME CORPORATION | 3 | $65 |
| Regeneron Healthcare Solutions, Inc. | 2 | $55 |
| Amgen Inc. | 2 | $43 |
| Lilly USA, LLC | 2 | $38 |
Products named: TREMFYA, NEMLUVIO, DUPIXENT, CIBINQO, SKYRIZI, COSENTYX, OTEZLA, RINVOQ.
Industry payments across IN — which companies pay providers there.
